All Articles

Combined lifestyle and type 2 diabetes mellitus among women with a history of GDM or HDP

Orforglipron versus oral semaglutide in type 2 diabetes, clinical implications of the ACHIEVE-3 trial

Tirzepatide for OSA and obesity: do we know the effect on cardiometabolic outcome?

Why wait? Early combination therapy in diabetic kidney disease: lessons from CONFIDENCE

MASLD epidemiology, natural history and diagnosis

Insulin physiology and metabolic control: current concepts and perspectives

Triglyceride-glucose waist-to-weight index and bone microarchitecture in type 2 diabetes: a machine-learning and regression analysis

Extracellular vesicle-mediated communication in diabetic cardiomyopathy: cellular mechanisms, metabolic remodeling, and emerging therapeutic strategies

Finerenone in type 1 diabetes and chronic kidney disease

Urinary extracellular vesicles detect altered renal circulation in human obesity

Multimorbidity comes to roost: insights from the LiverScreen project on the future burden of metabolic liver disease

Correction: Short-term L-arabinose administration alleviates MASLD by remodeling gut microbiota and activating hepatic ATF5-dependent mitochondrial unfolded protein response

Determinants of plasma branched-chain amino acids and associations with cardiometabolic biomarkers and proteomic signatures

Associations of cardiovascular-kidney-metabolic syndrome stage with trabecular bone score and bone mineral density

Liver transplantation in patients with metabolic dysfunction and alcohol-related liver disease (MetALD)

Liver muscle bone axis in metabolic dysfunction-associated steatotic liver disease

Predicting cardiovascular-kidney-metabolic multimorbidity in Chinese adults with overweight and obesity using machine learning: an internal evaluation

Estimation of liver fibrosis and cirrhosis risk using non-invasive biomarkers in people living with HIV and prediabetes in Tanzania